4,4,5,5-Tetramethyl-2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1,3,2-dioxaborolane, 97.0%, 250mg

Sistema de vacío LABOXACT® SEM serie EM 820, 1 pieza

METHYL 2-BROMO-3-IODOBENZOATE, 95.0%, 250mg

Phenyl 4-chlorobenzoate, 98%, 5g

tert-Butyl 3,3-difluoro-4-(((trifluoromethyl)sulfonyl)oxy)-3,6-dihydropyridine-1(2H)-carboxylate, 98%, 10g

2-Amino-5-chloro-6-methylpyrazine, 95.0%, 500mg

2-(4-Bromophenyl)piperidine, 97%, 25g

N-(4-(2-(Benzyl(methyl)amino)ethyl)phenyl)-5-(pyridin-3-yl)thiazol-2-amine hydrobromide, 98%, 100mg

5-(3,4-difluorophenyl)-4,5-dihydroisoxazole-3-carboxylic acid, 100mg

1-(1,1-Dimethylethyl) 1,1-cyclobutanedicarboxylate, 98%, 250mg

N-(4-Chloro-2,5-dimethoxyphenyl)-3-hydroxy-2-naphthamide, 95.0%, 5g

H-Thr(tBu)-OH, 95.0%, 25g

2-Acetoxy-5-(2-bromoacetyl)benzyl acetate, 95.0%, 1g